Phase Holographic Imaging PHI Stock Price

Phase Holographic Imaging PHI AB (publ) develops and markets instrumentation for non-invasive time-lapse imaging in Sweden and internationally. The company’s products include HoloMonitor M4, a live cell imaging microscope system; HoloMonitor M3, a bench-top time-lapse cytometer equipped with a motorized stage and variable magnification; HoloMonitor app Suite for cell imaging software facilitates kinetic live-cell tracking and analysis; HoloMonitor M4FL, a system for fluorescence; and HoloMonitor single tracking, kinetic dose response and cell mobility, cell morphology, wound healing, cell quality control, cell control, and kinetic cell proliferation assay. It offers HoloLids to eliminate image disturbances caused by surface vibrations and condensation inside the cell culture vessel; Vessel Holder to fix the culture vessel to the motorized stage; and HoloDry to keep optics for condensation of HoloMonitor free. Its products are used in cancer research, drug discovery and development, single cell analysis, cell counting, cell quality check, counting, proliferation, motility, migration, morphology, and tracking, as well as dose responses and wound healing. The company was incorporated in 1997 and is based in Lund, Sweden.